Edmund A Bermudez

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi Relation between markers of systemic vascular inflammation and smoking in women
    Edmund A Bermudez
    Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Boston, Massachusetts, USA
    Am J Cardiol 89:1117-9. 2002
  2. ncbi Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women
    Edmund A Bermudez
    Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02215, USA
    Arterioscler Thromb Vasc Biol 22:1668-73. 2002
  3. ncbi C-reactive protein, statins, and the primary prevention of atherosclerotic cardiovascular disease
    Edmund A Bermudez
    Center for Cardiovascular Disease Prevention, the Leducq Center for Cardiovascular Research, and the Divisions of Preventive Medicine and Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA
    Prev Cardiol 5:42-6. 2002
  4. ncbi Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial
    Nan Chiang
    Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA
    Proc Natl Acad Sci U S A 101:15178-83. 2004

Detail Information

Publications4

  1. ncbi Relation between markers of systemic vascular inflammation and smoking in women
    Edmund A Bermudez
    Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Boston, Massachusetts, USA
    Am J Cardiol 89:1117-9. 2002
  2. ncbi Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women
    Edmund A Bermudez
    Center for Cardiovascular Disease Prevention, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02215, USA
    Arterioscler Thromb Vasc Biol 22:1668-73. 2002
    ..Interleukin-6 (IL-6) and C-reactive protein (CRP) are markers of systemic vascular inflammation that herald atherothrombosis and may have important interrelationships with traditional cardiovascular risk factors...
  3. ncbi C-reactive protein, statins, and the primary prevention of atherosclerotic cardiovascular disease
    Edmund A Bermudez
    Center for Cardiovascular Disease Prevention, the Leducq Center for Cardiovascular Research, and the Divisions of Preventive Medicine and Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA
    Prev Cardiol 5:42-6. 2002
    ..Large-scale, randomized trials in the primary prevention of acute coronary events among individuals without overt hyperlipidemia but with evidence of elevated C-reactive protein are now needed to directly test this hypothesis...
  4. ncbi Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial
    Nan Chiang
    Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA
    Proc Natl Acad Sci U S A 101:15178-83. 2004
    ..These results also emphasize the importance of cell-cell interactions in the modulation of hemostatic, thrombotic, and inflammatory processes...